pH-Responsive Ionizable Lipid Nanoparticles for mRNA Delivery

Resolve Bottlenecks,
Find Innovative Solutions
Generate Solutions

Solution Overview

Problem

The instability and low cell penetrating potential of biologically active substances, particularly RNA molecules, pose challenges in developing effective drug delivery systems, especially for emerging clinical therapies like nucleic acid-based vaccines.

Innovation Solution

Development of ionizable lipids and lipid nanoparticles that encapsulate and deliver cargo molecules, including nucleic acids, by forming lipid nanoparticles with specific alkyl group combinations and structures.

Engineering Contradictions & Design Principles

VSEngineering Contradiction Analysis

1Reliability

If biologically active substances (particularly RNA molecules) are used for drug delivery, then therapeutic efficacy is improved, but stability and cell penetrating potential deteriorate

Engineering Contradiction:
Improvetherapeutic efficacyVSAvoidstability
Core Design Contradiction:
ReliabilityVSStability of the object's composition

Solution Approach 1:

The patent employs composite lipid formulations comprising multiple lipid components (ionizable lipid, helper lipid, structural lipid) to create lipid nanoparticles that encapsulate RNA cargo. This composite approach provides both the stability needed for RNA protection and the cell-penetrating capability for delivery, resolving the contradiction between RNA efficacy and stability.

Inventive Principle:
Principle #40Composite materials

Solution Approach 2:

The patent utilizes ionizable lipids that change their charge state based on pH environment. These lipids are neutral at physiological pH (providing stability) but become cationic in endosomal compartments (enabling cell penetration and RNA release). This parameter change resolves the contradiction by providing both stability and cell penetrating potential at different stages of delivery.

Inventive Principle:
Principle #35Parameter changes

2Reliability

If biologically active substances (particularly RNA molecules) are used for drug delivery, then therapeutic efficacy is improved, but cell penetrating potential deteriorates

Engineering Contradiction:
Improvetherapeutic efficacyVSAvoidcell penetrating potential
Core Design Contradiction:
ReliabilityVSEase of operation

Solution Approach 1:

The lipid nanoparticle formulation combines ionizable lipids with helper lipids and structural lipids to achieve synergistic effects. The ionizable lipid provides cell penetration capability through endosomal disruption, while helper and structural lipids maintain nanoparticle integrity, collectively enabling RNA to penetrate cells effectively.

Inventive Principle:
Principle #40Composite materials

Solution Approach 2:

The ionizable lipid's pH-dependent charge transition enables the nanoparticle to remain stable in circulation (neutral pH) while becoming actively cell-penetrating in the acidic endosomal environment. This parameter change allows the system to overcome the poor cell penetrating potential of naked RNA.

Inventive Principle:
Principle #35Parameter changes

Applied Scientific Principles

This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.

Function Achieved in This Case

Enhances the stability and cell penetrating ability of biologically active substances, improving the delivery efficiency of nucleic acids into cells.

Implementation Method 1

ionizable lipids, lipid nanoparticles for mRNA delivery

Methodology Applied
Scientific EffectPhase transition: Phase Change

Implementation Method 2

ionizable lipids

Methodology Applied
Scientific EffectIonization: Ionisation

Implementation Method 3

lipid-based nanoparticle compositions such as lipoplexes and liposomes have been used as packaging vehicles

Methodology Applied
Scientific EffectSelf-assembly: Self-Assembly

Implementation Method 4

These lipid-based nanoparticle compositions typically comprise a mixture of different lipids

Methodology Applied
Scientific EffectAmphiphilic structure formation: Amphiphiles

Data Source

PatentUS20250325492A1Ionizable lipids, lipid nanoparticles for mRNA delivery and methods of making the same
Publication Date: 2025.10.23 UNIVERSITY OF CINCINNATI
  • US20250325492A1 patent drawing
  • US20250325492A1 patent drawing
  • US20250325492A1 patent drawing

AI summary

A composition including ionizable lipids is provided. Methods of making the ionizable lipids are also provided. Also provided are compositions forming lipid nanoparticles, wherein the composition includes the ionizable lipid, a helper lipid, a structural lipid or sterol, and a polymer-conjugated lipid. Methods of using the ionizable lipid and lipid nanoparticles are also provided.